Joshua Jennings
Stock Analyst at TD Cowen
(3.17)
# 1,183
Out of 5,090 analysts
74
Total ratings
44.93%
Success rate
2.99%
Average return
Main Sectors:
Stocks Rated by Joshua Jennings
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CBLL CeriBell | Maintains: Buy | $36 → $20 | $19.72 | +1.42% | 3 | Nov 5, 2025 | |
| SENS Senseonics Holdings | Maintains: Buy | $25 → $15 | $6.62 | +126.59% | 2 | Nov 5, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $85 → $50 | $35.86 | +39.43% | 4 | Nov 5, 2025 | |
| DXCM DexCom | Maintains: Buy | $100 → $84 | $65.49 | +28.26% | 2 | Oct 31, 2025 | |
| HUMA Humacyte | Maintains: Buy | $5 → $3.5 | $1.23 | +184.55% | 3 | Aug 12, 2025 | |
| AVR Anteris Technologies Global | Initiates: Buy | $15 | $4.67 | +221.20% | 1 | Jan 7, 2025 | |
| PODD Insulet | Maintains: Buy | $264 → $324 | $304.49 | +6.41% | 1 | Jan 3, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $100 → $110 | $97.52 | +12.80% | 7 | Dec 12, 2024 | |
| TMDX TransMedics Group | Maintains: Buy | $175 → $120 | $136.51 | -12.09% | 9 | Nov 18, 2024 | |
| ALUR Allurion Technologies | Initiates: Buy | $50 | $1.70 | +2,841.18% | 1 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $143 → $119 | $94.28 | +26.22% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $60 | $36.23 | +65.61% | 2 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $83 → $80 | $77.03 | +3.86% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $45 | $4.39 | +925.06% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $100 → $70 | $86.19 | -18.78% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $185 | $201.93 | -8.38% | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $40 | $18.54 | +115.75% | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $365 → $400 | $364.02 | +9.88% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $60 | $70.79 | -15.24% | 4 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $34 | $20.92 | +62.52% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $14 → $18 | $6.60 | +172.73% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $6 → $25 | $17.68 | +41.40% | 1 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $130 | $125.08 | +3.93% | 9 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $5 | $2.41 | +107.47% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $117 | $101.36 | +15.43% | 3 | May 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $450 | $2.98 | +15,000.67% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $12 | $21.45 | -44.06% | 1 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $306 → $275 | $193.96 | +41.78% | 1 | Feb 7, 2020 |
CeriBell
Nov 5, 2025
Maintains: Buy
Price Target: $36 → $20
Current: $19.72
Upside: +1.42%
Senseonics Holdings
Nov 5, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $6.62
Upside: +126.59%
PROCEPT BioRobotics
Nov 5, 2025
Maintains: Buy
Price Target: $85 → $50
Current: $35.86
Upside: +39.43%
DexCom
Oct 31, 2025
Maintains: Buy
Price Target: $100 → $84
Current: $65.49
Upside: +28.26%
Humacyte
Aug 12, 2025
Maintains: Buy
Price Target: $5 → $3.5
Current: $1.23
Upside: +184.55%
Anteris Technologies Global
Jan 7, 2025
Initiates: Buy
Price Target: $15
Current: $4.67
Upside: +221.20%
Insulet
Jan 3, 2025
Maintains: Buy
Price Target: $264 → $324
Current: $304.49
Upside: +6.41%
Boston Scientific
Dec 12, 2024
Maintains: Buy
Price Target: $100 → $110
Current: $97.52
Upside: +12.80%
TransMedics Group
Nov 18, 2024
Maintains: Buy
Price Target: $175 → $120
Current: $136.51
Upside: -12.09%
Allurion Technologies
Oct 2, 2024
Initiates: Buy
Price Target: $50
Current: $1.70
Upside: +2,841.18%
Sep 6, 2024
Maintains: Hold
Price Target: $143 → $119
Current: $94.28
Upside: +26.22%
Aug 27, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $36.23
Upside: +65.61%
Aug 13, 2024
Maintains: Hold
Price Target: $83 → $80
Current: $77.03
Upside: +3.86%
Aug 8, 2024
Maintains: Buy
Price Target: $135 → $45
Current: $4.39
Upside: +925.06%
Jul 25, 2024
Downgrades: Hold
Price Target: $100 → $70
Current: $86.19
Upside: -18.78%
Jul 18, 2024
Maintains: Buy
Price Target: $195 → $185
Current: $201.93
Upside: -8.38%
May 10, 2024
Downgrades: Hold
Price Target: $40
Current: $18.54
Upside: +115.75%
Apr 11, 2024
Maintains: Buy
Price Target: $365 → $400
Current: $364.02
Upside: +9.88%
Mar 12, 2024
Maintains: Outperform
Price Target: $50 → $60
Current: $70.79
Upside: -15.24%
Aug 4, 2023
Maintains: Outperform
Price Target: $52 → $34
Current: $20.92
Upside: +62.52%
May 11, 2023
Maintains: Outperform
Price Target: $14 → $18
Current: $6.60
Upside: +172.73%
Dec 30, 2022
Maintains: Outperform
Price Target: $6 → $25
Current: $17.68
Upside: +41.40%
Dec 13, 2022
Maintains: Outperform
Price Target: $130
Current: $125.08
Upside: +3.93%
Nov 11, 2022
Maintains: Outperform
Price Target: $7 → $5
Current: $2.41
Upside: +107.47%
May 27, 2022
Maintains: Outperform
Price Target: $125 → $117
Current: $101.36
Upside: +15.43%
Dec 7, 2021
Initiates: Outperform
Price Target: $450
Current: $2.98
Upside: +15,000.67%
Sep 3, 2020
Initiates: Outperform
Price Target: $12
Current: $21.45
Upside: -44.06%
Feb 7, 2020
Downgrades: Market Perform
Price Target: $306 → $275
Current: $193.96
Upside: +41.78%